K. Shenoy

Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.

D. Doval, S. Nag, G. Bhattacharyya, 2009 .

LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.

S. Pervaiz, K. Shenoy, Yongfei Wu, 2009, Cancer research.

Thymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma Cells

M. Hande, S. Sethu, Manikandan Jayapal, 2010, PloS one.

Up-regulation of Death Receptors Mitogen-Activated Protein Kinase Activation and Mediated − Neuroblastoma Cells via Hydrogen Peroxide LY 303511 Enhances TRAIL Sensitivity of SHEP-1

S. Pervaiz, K. Shenoy, Yongfei Wu, 2009 .

Distinct roles for b-arrestin2 and arrestin-domain- containingproteinsinb 2 adrenergicreceptortrafficking

Sang-oh Han, K. Shenoy, R. Kommaddi, 2013 .

TRAILing death in cancer.

S. Pervaiz, K. Shenoy, Sin-Ming Huang, 2010, Molecular aspects of medicine.